Results of the review
Overall, 14 papers met the inclusion criteria: 3 RCTs, 3 retrospective cohort studies, 1 case-control study, and 7 uncontrolled case series or case reports. It was not possible to calculate the exact number of the included participants from the information given; at least 2,660 individuals participated.
Findings from 2 RCTs suggested that erythromycin was not effective as a prophylaxis. However, both trials had methodological problems, including small sample size. Results from a larger trial showed a statistically-significant difference for the proportion of cases with positive bacteriological cultures (erythromycin 6.6% versus placebo 20.3%; relative rate difference 67.5%, 95% confidence intervals: 7.6, 88.7). However, there was no significant difference in the serological response between the groups. The erythromycin group had significantly more adverse advents than the placebo group (34.3% versus 15.9%, p=0.0003), which were mainly diarrhoea and nausea. The results from the retrospective cohort studies, case-control studies, and uncontrolled case series and case reports generally favoured the use of erythromycin as a prophylaxis for close contacts. Two cohort studies reported gastrointestinal adverse effects with erythromycin use.
Authors' conclusions
There was only weak evidence to support the use of erythromycin prophylaxis. The overall quality of this evidence was judged to be II-2, i.e. evidence obtained from well-designed cohort or case-controlled analytical studies, preferably from more than one centre or research group). The effect was at best modest when compared with the protection conferred by an effective whole-cell vaccine. There was no evidence of any benefit to contacts other than household-type contacts.
CRD commentary
Adequate details were given of the review objectives and search strategy. It is possible that further material may have been identified had other sources been accessed and language restrictions applied. A discussion about the possible impact of publication bias would have been useful. Some of the selection criteria for the primary studies were unclear, particularly in connection with the outcomes. Some details of the primary material were given in the text and tables. However, the studies were only classified according to design, with no systematic assessment of the methodological quality of the individual evaluations, thus the narrative synthesis was sometimes difficult to interpret. The narrative method of summary was appropriate given the likely heterogeneity between the studies. There were no details about the review process, i.e. how many reviewers were involved, how decisions were made, how the data were extracted, and how disagreements were resolved. The authors' conclusions appear to follow-on from the evidence presented in the review.
